P
PolyRemedy
Advanced wound care solutions leveraging personalized treatment plans and innovative technology
About PolyRemedy
PolyRemedy specializes in advanced wound care solutions, focusing on personalized treatment plans and innovative technology to improve patient outcomes. The company serves healthcare providers, including hospitals and clinics, by offering tailored wound care management systems that integrate seamlessly into existing medical workflows. Operating in the healthcare technology market, PolyRemedy's business model revolves around the sale and support of its proprietary wound care products and services. Revenue is generated through direct sales, subscriptions for ongoing support, and licensing of its technology. The company's core product includes a comprehensive wound care management system that uses data analytics to customize treatment plans for individual patients, thereby enhancing the efficiency and effectiveness of wound care.
Source: Dealroom company dataAt a glance
- Founded
- 2004
- Headquarters
- Mountain View, United States
- Sector
- Health
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- MAMedVenture Associates
- AVAdvanced Technology Ventures
IDG Ventures
Flybridge Capital Partners
Series B and later1 investor entered at this stage
Delphi Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about PolyRemedy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PolyRemedy on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.